Interestingly, a phase II clinical trial testing androgen deprivation therapy and ICB reported a reduction in PSA levels and tumor reduction in 25% of patients99 and a phase I clinical trial of the PCa vaccine sipuleucel-T combined with ICB gave promising results. The gene discussed is KLK3; the disease is neoplasm.